Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
about
Moving toward consensus on diagnosis and management of severe asthma in children.Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history.Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab.Potential new targets for drug development in severe asthmaThe Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cellsTreating Pediatric Asthma According GuidelinesTolerability of Omalizumab in Asthma as a Major Compliance Factor: 10-Year Follow Up
P2860
Q47863226-427330E6-5FA1-4F36-987C-BA602B4E7DD8Q52584472-6BA9696C-81C0-498A-BEC8-EEF71FDE7ECCQ55517296-08E40540-F9A5-423F-A24B-72D9E272EF75Q58564315-2F392C24-23C4-404A-871A-EB89E0EE83C0Q58700697-D2C98490-7094-4BE8-BFEE-2072DC7A6BCBQ58712869-AB1C386C-D914-4251-9A32-883151ACE2ADQ59136709-20F447D4-0A0D-417F-BC61-6DE3418F8229
P2860
Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Omalizumab in children with un ...... ial and real-world experience.
@en
type
label
Omalizumab in children with un ...... ial and real-world experience.
@en
prefLabel
Omalizumab in children with un ...... ial and real-world experience.
@en
P2093
P1476
Omalizumab in children with un ...... ial and real-world experience.
@en
P2093
Ahmar Iqbal
Antoine Deschildre
Benjamin Ortiz
Benjamin Trzaskoma
Bob Lanier
Bradley E Chipps
Farid Kianifard
Gunilla Hedlin
Henry Milgrom
Karin Rosén
P304
P356
10.1016/J.JACI.2017.03.002
P407
P577
2017-05-01T00:00:00Z